<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To assess the distribution of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in Taiwan according to the WHO (World Health Organization) classification, 175 recently diagnosed cases of malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were studied and the clinicopathologic data were analyzed </plain></SENT>
<SENT sid="1" pm="."><plain>B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> accounted for 57.1% of cases, T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> 38.9%, and Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> 4% </plain></SENT>
<SENT sid="2" pm="."><plain>Extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> predominated (55.4%) </plain></SENT>
<SENT sid="3" pm="."><plain>The most common subtype of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (33.1%) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types believed to be derived from germinal center (GC) B-cells including follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (4.6%), Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (1.7%), Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (4.0%), and GC-like diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (as defined by combined expression of bc1-6 and CD10) were rather uncommon as compared to frequencies seen in series from Western countries </plain></SENT>
<SENT sid="5" pm="."><plain>The common T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> included nasal and extranasal NK/T cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (7.4%), <z:e sem="disease" ids="C0026948" disease_type="Neoplastic Process" abbrv="">mycosis fungoides</z:e> (7.4%), and unspecified peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (6.9%) </plain></SENT>
<SENT sid="6" pm="."><plain>Adult T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> was very uncommon and accounts for only 0.6% </plain></SENT>
<SENT sid="7" pm="."><plain>The proportional increase in T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> that were unrelated to type I human T-cell lymphotropic virus (HTLV-1) may be linked to differential Epstein-Barr virus (EBV) <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The survival data revealed that mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, NK/T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, unspecified peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and subcutaneous <z:mp ids='MP_0011164'>panniculitis</z:mp>-like T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> had an aggressive course </plain></SENT>
<SENT sid="9" pm="."><plain>Our results confirm the utility of the WHO classification scheme for prognostic stratification and further highlight the distinctive distribution pattern of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in Taiwan including the higher relative incidence of T cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and the rarity of germinal center-derived B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>